Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Regen BioPharma Inc RGBP

Regen BioPharma Inc. is a biotechnology company. The Company is engaged on the immunology and immunotherapy space. The Company is focused on novel technologies through pre-clinical and Phase I/ II clinical trials. It is involved on mRNA and small molecule therapies for treating cancer and autoimmune disorders. It is also developing products treating blood disorders using small molecules and... see more

OTCPK:RGBP - Post Discussion

Regen BioPharma Inc > Presenting on the Emerging Growth Conference 67 Day 1 on Feb
View:
Post by whytestocks on Feb 06, 2024 11:00pm

Presenting on the Emerging Growth Conference 67 Day 1 on Feb

BREAKING NEWS: $RGBP Presenting on the Emerging Growth Conference 67 Day 1 on February 7 Register NowMIAMI, Feb. 06, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 67 th Emerging Growth Conference on February 7 & 8, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, wit...RGBP - Presenting on the Emerging Growth Conference 67 Day 1 on February 7 Register Now
Be the first to comment on this post